相关实验视频
Updated: Jul 27, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
225
非编码RNA的相互关联网格:在风湿性关节炎的发病过程中的一个重要方面
Mohd Saquib1,2, Prachi Agnihotri1,2, Monu1,2
1Council of Scientific & Industrial Research (CSIR)-Institute of Genomics and Integrative Biology, Mall Road, Delhi University Campus, Delhi, 110007, India.
Molecular biology reports
|June 9, 2023
概括
非编码RNA,包括微RNA和长非编码RNA,是类风湿性关节炎 (RA) 病原体的关键调节者. 了解它们的作用为这种炎症性关节疾病提供了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 类风湿性关节炎 (RA) 是一种由炎症驱动的破坏性自身免疫性关节疾病.
- RNA分子在细胞平衡,结构,功能和调节中起着至关重要的作用.
- 人们越来越认识到,编码和非编码RNA在RA病变发生过程中的参与.
研究的目的:
- 探索非编码RNAs在类风湿性关节炎早期发病过程中的作用.
- 为了更好地了解RA发展,识别非编码RNA目标.
- 研究基于非编码RNA函数的RA的新型治疗策略.
主要方法:
- 对有关炎症和自身免疫性疾病中非编码RNA功能的现有文献的综述.
- 对各种非编码RNA类型 (例如miRNA,lncRNA,circRNA,piRNA) 的调节机制的分析.
- 检查RA中非编码RNAs在转录前和转录后的调节作用.
主要成果:
- 家政RNAs (rRNA,tRNA) 和调节RNAs (miRNA,circRNA,piRNA,lncRNA) 都与RA炎症有关.
- 非编码RNA表达的变化与RA发病的特定疾病影响有关.
- 非编码RNA在转录前和转录后的两级都发挥了调控作用.
结论:
- 非编码RNA是类风湿性关节炎背后的炎症过程的关键调节者.
- 对非编码RNA目标的进一步研究可以阐明RA发展机制.
- 非编码RNAs代表了未来RA治疗干预的有希望的目标.
相关概念视频
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K

